JP2005533766A5 - - Google Patents

Download PDF

Info

Publication number
JP2005533766A5
JP2005533766A5 JP2004506794A JP2004506794A JP2005533766A5 JP 2005533766 A5 JP2005533766 A5 JP 2005533766A5 JP 2004506794 A JP2004506794 A JP 2004506794A JP 2004506794 A JP2004506794 A JP 2004506794A JP 2005533766 A5 JP2005533766 A5 JP 2005533766A5
Authority
JP
Japan
Prior art keywords
hydrogen
pharmaceutical composition
tetracycline
cmt
tetracycline compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2004506794A
Other languages
English (en)
Japanese (ja)
Other versions
JP2005533766A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2003/015744 external-priority patent/WO2003099270A1/en
Publication of JP2005533766A publication Critical patent/JP2005533766A/ja
Publication of JP2005533766A5 publication Critical patent/JP2005533766A5/ja
Pending legal-status Critical Current

Links

JP2004506794A 2002-05-20 2003-05-20 アレルギー反応の治療方法 Pending JP2005533766A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US38212702P 2002-05-20 2002-05-20
PCT/US2003/015744 WO2003099270A1 (en) 2002-05-20 2003-05-20 Methods of treating allergic reactions

Publications (2)

Publication Number Publication Date
JP2005533766A JP2005533766A (ja) 2005-11-10
JP2005533766A5 true JP2005533766A5 (enExample) 2006-07-06

Family

ID=29584360

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2004506794A Pending JP2005533766A (ja) 2002-05-20 2003-05-20 アレルギー反応の治療方法

Country Status (7)

Country Link
US (1) US20050164993A1 (enExample)
EP (1) EP1505961A4 (enExample)
JP (1) JP2005533766A (enExample)
KR (1) KR20050007553A (enExample)
AU (1) AU2003245295B2 (enExample)
CA (1) CA2485677C (enExample)
WO (1) WO2003099270A1 (enExample)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004014434A1 (en) * 2002-08-09 2004-02-19 Durkin Helen G A method for monitoring the effectiveness of tetracycline in the treatment of asthma
IL152486A0 (en) 2002-10-25 2003-05-29 Meir Eini Alcohol-free cosmetic and pharmaceutical foam carrier
US20080138296A1 (en) 2002-10-25 2008-06-12 Foamix Ltd. Foam prepared from nanoemulsions and uses
US9265725B2 (en) 2002-10-25 2016-02-23 Foamix Pharmaceuticals Ltd. Dicarboxylic acid foamable vehicle and pharmaceutical compositions thereof
AU2003279493B2 (en) 2002-10-25 2009-08-20 Foamix Pharmaceuticals Ltd. Cosmetic and pharmaceutical foam
US7700076B2 (en) 2002-10-25 2010-04-20 Foamix, Ltd. Penetrating pharmaceutical foam
US9668972B2 (en) 2002-10-25 2017-06-06 Foamix Pharmaceuticals Ltd. Nonsteroidal immunomodulating kit and composition and uses thereof
US10117812B2 (en) 2002-10-25 2018-11-06 Foamix Pharmaceuticals Ltd. Foamable composition combining a polar solvent and a hydrophobic carrier
US7704518B2 (en) 2003-08-04 2010-04-27 Foamix, Ltd. Foamable vehicle and pharmaceutical compositions thereof
WO2005046618A2 (en) * 2003-11-06 2005-05-26 Research Foundation Of State University Of New York, The Methods of treating eczema
WO2006045152A1 (en) * 2004-10-29 2006-05-04 Mayne Pharma International Pty Ltd Improved tabletting process
US20080260655A1 (en) 2006-11-14 2008-10-23 Dov Tamarkin Substantially non-aqueous foamable petrolatum based pharmaceutical and cosmetic compositions and their uses
JP5395052B2 (ja) * 2007-03-23 2014-01-22 モレキュラー リサーチ センター インコーポレイテッド 炎症を処置するための組成物および方法
US8636982B2 (en) 2007-08-07 2014-01-28 Foamix Ltd. Wax foamable vehicle and pharmaceutical compositions thereof
WO2009069006A2 (en) 2007-11-30 2009-06-04 Foamix Ltd. Foam containing benzoyl peroxide
WO2009072007A2 (en) 2007-12-07 2009-06-11 Foamix Ltd. Carriers, formulations, methods for formulating unstable active agents for external application and uses thereof
CA2760186C (en) 2009-04-28 2019-10-29 Foamix Ltd. Foamable vehicle and pharmaceutical compositions comprising aprotic polar solvents and uses thereof
WO2011013009A2 (en) 2009-07-29 2011-02-03 Foamix Ltd. Non surfactant hydro-alcoholic foamable compositions, breakable foams and their uses
WO2011013008A2 (en) 2009-07-29 2011-02-03 Foamix Ltd. Non surface active agent non polymeric agent hydro-alcoholic foamable compositions, breakable foams and their uses
CN102686205A (zh) 2009-10-02 2012-09-19 弗艾米克斯有限公司 局部四环素组合物
US9849142B2 (en) 2009-10-02 2017-12-26 Foamix Pharmaceuticals Ltd. Methods for accelerated return of skin integrity and for the treatment of impetigo
US20140221320A1 (en) * 2011-07-08 2014-08-07 The Research Foundation For The State University Of New York Topical minocycline ointment for suppression of allergic skin responses
US20170182070A1 (en) 2014-10-08 2017-06-29 Mayne Pharma International Pty Ltd. Controlled Release Doxycycline
CA2978573A1 (en) 2016-09-08 2018-03-08 Foamix Pharmaceuticals Ltd. Compositions and methods for treating rosacea and acne

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2730930B1 (fr) * 1995-02-27 1997-04-04 Oreal Utilisation d'inhibiteurs de no-synthase pour diminuer l'effet irritant cutane de produits utilises dans le domaine cosmetique ou pharmaceutique
US5700816A (en) * 1995-06-12 1997-12-23 Isakson; Peter C. Treatment of inflammation and inflammation-related disorders with a combination of a cyclooxygenase-2 inhibitor and a leukotriene A4 hydrolase inhibitor
US5837696A (en) * 1997-01-15 1998-11-17 The Research Foundation Of State University Of New York Method of inhibiting cancer growth
US5998390A (en) * 1998-09-28 1999-12-07 The Research Foundation Of State University Of New York Combination of bisphosphonate and tetracycline
US6506740B1 (en) * 1998-11-18 2003-01-14 Robert A. Ashley 4-dedimethylaminotetracycline derivatives
US6946453B2 (en) * 1998-11-18 2005-09-20 Collagenex Pharmaceuticals, Inc. 4-dedimethylaminotracycline derivatives
US6613756B2 (en) * 2000-05-05 2003-09-02 Wisconsin Alumni Research Foundation Use of tetracycline derivatives in treating multiple sclerosis
US6610274B1 (en) * 2000-12-22 2003-08-26 Wallace J. Gardner Anti-inflammatory composition comprising tetracycline
EP2332547A1 (en) * 2001-07-13 2011-06-15 Paratek Pharmaceuticals, Inc. Tetracyclines for the treatment of inflammatory bowel disease
WO2004014434A1 (en) * 2002-08-09 2004-02-19 Durkin Helen G A method for monitoring the effectiveness of tetracycline in the treatment of asthma

Similar Documents

Publication Publication Date Title
JP2005533766A5 (enExample)
JP2005523313A5 (enExample)
CA2485677A1 (en) Methods of treating allergic reactions
JP2004536046A5 (enExample)
AU2002256092C1 (en) Controlled delivery of tetracycline compounds and tetracycline derivatives
JP2021066744A5 (ja) ブプロピオンおよびデキストロメトルファンを含む組成物
AU2002256092A1 (en) Controlled delivery of tetracycline compounds and tetracycline derivatives
CA2440472A1 (en) Methods of treating acne
JP2010053146A (ja) インターロイキン−10生成を増進するためのテトラサイクリン化合物の使用方法
JPH10503522A (ja) 化学療法剤とともに使用するための防御性プロスタグランジン
WO2004078129A2 (en) Method for decreasing low density lipoprotein
JP2004532828A5 (enExample)
JP2006508128A5 (enExample)
US20080233151A1 (en) Use of non-antibacterial tetracycline analogs and formulations thereof for the treatment of bacterial exotoxins
RU2005105691A (ru) Пероральное введение кальцитонина
JP2002525299A (ja) 新規白内障形成抑制剤
US20050282786A1 (en) Method for reducing c-rective protein levels with non-antibacterial tetracycline formulations
JP2008519848A5 (enExample)
AU2005222937B2 (en) Method for treating aortic stenosis with non-antibacterial tetracycline formulations
JP2007535502A5 (enExample)
WO2007075269A2 (en) Method for inhibiting tooth displacement with non-antibacterial tetracyline formulations
HK40087326A (zh) γ-羟基丁酸衍生物的修饰释放组合物
AU2018303807A1 (en) Treatment of non-inflammatory lesions
RU2009148830A (ru) Нерамексан в лечении нистагма
JPWO2023097276A5 (enExample)